Antihypertensives/diuretics and skin cancer

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/24773
• EU PAS number:
  EUPAS24772
• Study ID:
  24773
• Official title and acronym:
  Antihypertensives/diuretics and skin cancer
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  This study aims to provide a review of existing available evidence regarding the association between hydrochlorothiazide (HCTZ) / anti-hypertensive drugs and non-melanoma skin cancer (NMSC) / malignant melanoma (MM), together with a quality appraisal of the existing studies
• Study status:
  Finalised

Research institution and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 23/01/2018

Actual: 23/01/2018

Study start date

Planned: 23/01/2018

Actual: 23/01/2018

Date of final study report

Planned: 06/08/2018

Actual: 06/08/2018

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable